Relationship between the G75A polymorphism in the apolipoprotein A1 (ApoA1) gene and the lipid regulatory effects of pravastatin in patients with hyperlipidemia.

Liu, T N; Wu, C T; He, F; Yuan, W; Li, S X; Li, H W; Yu, H Y; Wu, M

Liu, T N; Wu, C T; He, F; Yuan, W; Li, S X; Li, H W; Yu, H Y; Wu, M.

Afiliação

Liu TN; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Wu CT; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
He F; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Yuan W; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Li SX; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Li HW; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Yu HY; Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China.
Wu M; The People's Hospital of Tangshan, Tangshan, China.

Genet Mol Res ; 15(2)2016 Jun 17.

Article em En | MEDLINE | ID: mdl-27323196

Assuntos

Anticolesterolemiantes/uso terapêutico; Apolipoproteína A-I/genética; Hiperlipidemias/genética; Lipoproteínas/sangue; Polimorfismo de Nucleotídeo Único; Pravastatina/uso terapêutico; Álcoois Graxos/uso terapêutico; Humanos; Hiperlipidemias/sangue; Hiperlipidemias/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pravastatina / Apolipoproteína A-I / Polimorfismo de Nucleotídeo Único / Hiperlipidemias / Lipoproteínas / Anticolesterolemiantes Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google